Authors: | Robert, C.; Larkin, J.; Ascierto, P. A.; Long, G. V.; Hassel, J. C.; Schadendorf, D.; Hodi, F. S.; Lebbé, C.; Grob, J. J.; Grossmann, K.; Wagstaff, J.; Chesney, J.; Hogg, D.; Bechter, O.; Márquez-Rodas, I.; Pavlick, A. C.; Walker, D.; Bhore, R.; Postow, M. A.; Wolchok, J. D. |
Abstract Title: | Characterization of complete responses (CRs) in patients with advanced melanoma (MEL) who received the combination of nivolumab (NIVO) and ipilimumab (IPI), NIVO or IPI alone |
Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
Journal Title: | Annals of Oncology |
Volume: | 28 |
Issue: | Suppl. 5 |
Meeting Dates: | 2017 Sep 8-12 |
Meeting Location: | Madrid, Spain |
ISSN: | 0923-7534 |
Publisher: | Oxford University Press |
Date Published: | 2017-09-01 |
Start Page: | mdx377 |
Language: | English |
ACCESSION: | WOS:000411324003125 |
PROVIDER: | wos |
DOI: | 10.1093/annonc/mdx377 |
Notes: | Meeting Abstract: 1213O -- Source: Wos |